Sennosides And Docusate Sodium
NDC Package 63739-432-01
Package Information
Sennosides And Docusate Sodium is take preferably at bedtime or as directed by a doctor If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed the maximum dosage) or decrease dose until you are comfortable.AgeStarting DoseMaximum DoseAdults and children 12 years of age and older2 tablets once a day4 tablets twice a dayChildren 6 to under 12 years1 tablet once a day2 tablets twice a dayChildren 2 to under 6 years1/2 tablet once a day1 tablets twice a dayChildren under 2 yearsask a doctorask a doctor. Marketed by Mckesson Packaging Services A Business Unit Of Mckesson Corporation, this product is identified by NDC 63739-432 and is authorized under FDA application part334.
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63739 - Mckesson Packaging Services A Business Unit Of Mckesson Corporation
- 63739-432 - Sennosides And Docusate Sodium
- 63739-432-01 - 25 BLISTER PACK in 1 BOX, UNIT-DOSE / 30 TABLET in 1 BLISTER PACK
- 63739-432 - Sennosides And Docusate Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63739-432). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63739-432-01 identifies a specific commercial package of 25 blister pack in 1 box, unit-dose / 30 tablet in 1 blister pack of Sennosides And Docusate Sodium, labeled by Mckesson Packaging Services A Business Unit Of Mckesson Corporation. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Packaging Services A Business Unit Of Mckesson Corporation on October 11, 2007. The current certification is valid through December 31, 2022.
How is this Mckesson Packaging Services A Business Unit Of Mckesson Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63739043201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 25 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
